Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock
Key facts
- Who runs it
- University Hospital, Brest
- Where
- France17 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 535 people enrolled
- Started
- 4 Jun 2019
- Ended
- 8 Jan 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Minifluid challenge
- Usual practice
- Record updated
- 19 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Adult patient (Age > 18 years)
- Admitted in ICU for less than 3 days
- Abdominal (excepted urinary tract infection) or pulmonary related septic shock, defined by SEPSIS III criteria diagnosed within less than 12 hours
- Written consent or oral by the patient (and/or consent signed by the next of skin)
- Patient has social security affiliation or who beneficiary of such social security
Who cannot take part
- Cardiac arrest
- Allergy to albumin
- Patient with life expectancy inferior to 24 hours at the time of inclusion
- Pregnancy
- Traumatic brain injury
- Limitation of invasive therapeutics, palliative care
- Patient under guardianship or curatorship
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Many observational studies have highlighted an independent association between fluid overload and clinical outcomes during septic shock. To optimize fluid balance, clinician has several options to consider carefully fluid administration and avoid fluid overload. More than a general restrictive approach, a pragmatic, individual tailored approach should be considered to optimize patients' hemodynamics during acute circulatory failure. Many advances in hemodynamic monitoring were described. Mini-fluid challenge appears to be a sensible method to use for bedside assessment to optimize fluid infusion. The next step for hemodynamic management in the ICU should be to test a hemodynamic goal-directed approach to better control fluid management and eventually improve patient's outcome. The main objective of the GOAL study is to evaluate a pragmatic optimization fluid management protocol tailored to each patient's hemodynamic status based on mini-fluid challenges. This intervention will be compared to usual management based on the latest guidelines. This intervention aims to decrease organ dysfunction during septic shock. This is the first large clinical trial designed to test this hypothesis.
The 2 groups in the trial
- Minifluid challengeTreatment being tested
100 ml of 4% Albumin will be deliver to assess fluid responsiveness
- ControlTreatment being tested
Patient will be treated as defined by most recent surviving sepsis campaign guidelines
Treatment: Usual practice
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock: A Multicenter, Stepped Wedge Cluster Randomized Trial
- Record updated
- 19 September 2025